Dr. Geisse is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2290 Sacramento St
www.solderm.com
Vallejo, CA 94590Phone+1 707-643-5785Fax+1 707-643-8810
Summary
- I am a board certified dermatologist, dermatologic surgery, and dermatopathologist with a referral dermatopathology practice.
I am also a fellowship trained board certified Mohs surgeon specializing in high risk central facial skin cancers and reconstruction.
Education & Training
- University of California (San Francisco)Fellowship, Dermatopathology, 1990 - 1991
- University of California (San Francisco)Fellowship, Micrographic Surgery and Dermatologic Oncology, 1989 - 1990
- University of California (San Francisco)Residency, Dermatology, 1986 - 1989
- University of North Carolina HospitalsInternship, Internal Medicine, 1985 - 1986
- Indiana University School of MedicineClass of 1985, MD, With Highest Distinction; AOA
- Stanford UniversityB.A., Human Biology, 1980
- Stanford UniversityB.A., Human Biology, 1980
- Stanford UniversityB.A., Human Biology, 1980
Certifications & Licensure
- CA State Medical License 1986 - 2026
- NV State Medical License 1996 - 2007
- NC State Medical License 1985 - 1999
- American Board of Dermatology Dermatology
- American Board of Dermatology Dermatopathology
Awards, Honors, & Recognition
- Best Doctors in America
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
- Distinguished Service Award American College of Mohs Micrographic Surgery, 2011
- Join now to see all
Publications & Presentations
PubMed
- 30 citationsMedical therapies for non-melanoma skin cancer.Arun K. Chakrabarty, John K. Geisse
Clinics in Dermatology. 2004-05-01 - 276 citationsTherapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% creamKarl R. Beutner, John K. Geisse, Donita Helman, Terry L. Fox, Angela Ginkeld
Journal of the American Academy of Dermatology. 1999-12-01 - 344 citationsImiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studiesJohn K. Geisse, Ivor Caro, Jane S. Lindholm, Loren E. Golitz, Patti Stampone
Journal of the American Academy of Dermatology. 2004-05-01
Journal Articles
- Mohs micrographic surgery and partial amputation preserving function and aesthetics in digits: case reports of digital dermatofibrosarcoma protuberans and invasive mel...Do, Alice; Goleno, K; Geisse, JK, Dermatolg Surg, 1/1/2006
- Imiquimod: A Viewpoint by John GeisseGeisse, John, Am. Journal of Clinical Dermatology, 1/1/2005
- Medical Therapies for Non-Melanoma Skin CancerChakrabarty, A., Geisse, JK, Clinics in Dermatology, 5/1/2004
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Apthous Ulcers Associated With Imiquimod and the Treatment of Actinic Chelitis.Arun K. Chakrabarty, MD, Serena Mraz, MD, John K. Geisse, MD, Nancy J. Anderson, MD, JAAD, 2/1/2005
- Two Dose Response Studies Evaluating Imiquimod 5% Cream in the Treatment of Primary Superficial Basal Cell CarcinomaGeisse, JK, Marks, R, Owens, ML, Fox, TL, 59th Annual Meeting AAD, 3/1/2001
- "Two Dose Response Studies Evaluating Imiquimod 5% Cream in the Treatment of Primary Superficial Basal Cell Carcinoma"Geisse, JK, Marks, R, Owens, ML, Fox, TL, 59th Annual Meeting AAD, 3/1/2001
- Join now to see all
Authored Content
- Early Detection and Prompt Treatment of Squamous Cell Carcinoma in the Very ElderlyNovember 2022
Professional Memberships
- Fellow
- Fellow
- Member
- Member
- American Society of DermatopathologyFellow
- American College of Mohs Surgery and Cutaneous OncologyFellow
- Member
Industry Relationships
- Scientific Advisory Board Member, DermaSensorAdvisor to start up company with a novel device which uses elastic tissue scattering spectroscopy to screen all types of skin lesions for malignant versed benign spectroscopic signatures intended to help clinicians better screen patients for early detection of skin cancers.Disclosure: Stock holder; unpaid position.2014 - Present
External Links
- Solano Dermatologyhttps://www.solanodermatology.com
- SolDerm Vitaminshttps://solderm.com/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: